{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T14:10:52Z","timestamp":1789567852391,"version":"build-2803163510"},"reference-count":45,"publisher":"Spandidos Publications","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,1]]},"DOI":"10.3892\/ijo.2015.3240","type":"journal-article","created":{"date-parts":[[2015,11,9]],"date-time":"2015-11-09T11:01:48Z","timestamp":1447066908000},"page":"409-420","source":"Crossref","is-referenced-by-count":40,"title":["Synergistic anticancer effects of cisplatin and histone deacetylase inhibitors (SAHA and TSA) on cholangiocarcinoma cell lines"],"prefix":"10.3892","volume":"48","author":[{"given":"MD. ALI","family":"ASGAR","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"GULSIRI","family":"SENAWONG","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"BANCHOB","family":"SRIPA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"THANASET","family":"SENAWONG","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2015,11,9]]},"reference":[{"key":"key20180107185539_b1-ijo-48-01-0409","first-page":"701","article-title":"Genes and cholangiocarcinoma","volume":"40","author":"Sawanyawisuth","year":"2009","journal-title":"Southeast Asian J Trop Med Public Health"},{"issue":"Suppl 2","key":"key20180107185539_b2-ijo-48-01-0409","doi-asserted-by":"crossref","first-page":"ii93","DOI":"10.1093\/annonc\/mdi712","article-title":"The role of chemotherapy in cholangiocarcinoma","volume":"16","author":"Thongprasert","year":"2005","journal-title":"Ann Oncol"},{"issue":"Suppl 4","key":"key20180107185539_b3-ijo-48-01-0409","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0169-5002(02)00168-X","article-title":"Challenging the platinum combinations in the chemotherapy of NSCLC","volume":"38","author":"Douillard","year":"2002","journal-title":"Lung Cancer"},{"key":"key20180107185539_b4-ijo-48-01-0409","doi-asserted-by":"crossref","first-page":"7265","DOI":"10.1038\/sj.onc.1206933","article-title":"Cisplatin: Mode of cytotoxic action and molecular basis of resistance","volume":"22","author":"Siddik","year":"2003","journal-title":"Oncogene"},{"key":"key20180107185539_b5-ijo-48-01-0409","first-page":"1233","article-title":"Sequence-dependent interaction between cisplatin and histone deacetylase inhibitors in human oral squamous cell carcinoma cells","volume":"28","author":"Sato","year":"2006","journal-title":"Int J Oncol"},{"key":"key20180107185539_b6-ijo-48-01-0409","doi-asserted-by":"crossref","first-page":"630543","DOI":"10.1155\/2012\/630543","article-title":"Molecular pathogenesis of cholangiocarcinoma","volume":"2012","author":"Fava","year":"2012","journal-title":"Int J Hepatol"},{"key":"key20180107185539_b7-ijo-48-01-0409","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1002\/med.20024","article-title":"Histone deacetylation in epigenetics: An attractive target for anticancer therapy","volume":"25","author":"Mai","year":"2005","journal-title":"Med Res Rev"},{"key":"key20180107185539_b8-ijo-48-01-0409","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1517\/14728214.9.1.135","article-title":"Histone modification enzymes: Novel targets for cancer drugs","volume":"9","author":"Kristeleit","year":"2004","journal-title":"Expert Opin Emerg Drugs"},{"key":"key20180107185539_b9-ijo-48-01-0409","doi-asserted-by":"crossref","first-page":"5570","DOI":"10.1158\/1078-0432.CCR-06-0367","article-title":"Antitumor activity of suberoylanilide hydroxamic acid against thyroid cancer cell lines in vitro and in vivo","volume":"12","author":"Luong","year":"2006","journal-title":"Clin Cancer Res"},{"key":"key20180107185539_b10-ijo-48-01-0409","first-page":"3578","article-title":"Phase I clinical trial of histone deacetylase inhibitor: Suberoylanilide hydroxamic acid administered intravenously","volume":"9","author":"Kelly","year":"2003","journal-title":"Clin Cancer Res"},{"key":"key20180107185539_b11-ijo-48-01-0409","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1517\/13543784.16.7.1111","article-title":"Vorinostat: A new oral histone deacetylase inhibitor approved for cutaneous T-cell lymphoma","volume":"16","author":"Duvic","year":"2007","journal-title":"Expert Opin Investig Drugs"},{"key":"key20180107185539_b12-ijo-48-01-0409","first-page":"37","article-title":"Romidepsin in the treatment of cutaneous T-cell lymphoma","volume":"2","author":"Jain","year":"2011","journal-title":"J Blood Med"},{"key":"key20180107185539_b13-ijo-48-01-0409","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.7164\/antibiotics.53.1191","article-title":"Mechanism of cell cycle arrest caused by histone deacetylase inhibitors in human carcinoma cells","volume":"53","author":"Kim","year":"2000","journal-title":"J Antibiot (Tokyo)"},{"key":"key20180107185539_b14-ijo-48-01-0409","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1038\/bjc.2011.532","article-title":"Differential response of cancer cells to HDAC inhibitors trichostatin A and depsipeptide","volume":"106","author":"Chang","year":"2012","journal-title":"Br J Cancer"},{"key":"key20180107185539_b15-ijo-48-01-0409","doi-asserted-by":"crossref","first-page":"923824","DOI":"10.1155\/2010\/923824","article-title":"Preclinical studies of chemotherapy using histone deacetylase inhibitors in endometrial cancer","volume":"2010","author":"Takai","year":"2010","journal-title":"Obstet Gynecol Int"},{"key":"key20180107185539_b16-ijo-48-01-0409","doi-asserted-by":"crossref","first-page":"5705","DOI":"10.1073\/pnas.93.12.5705","article-title":"Second generation hybrid polar compounds are potent inducers of transformed cell differentiation","volume":"93","author":"Richon","year":"1996","journal-title":"Proc Natl Acad Sci USA"},{"key":"key20180107185539_b17-ijo-48-01-0409","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.canlet.2012.09.018","article-title":"Combination therapy: Histone deacetylase inhibitors and platinum-based chemotherapeutics for cancer","volume":"329","author":"Diyabalanage","year":"2013","journal-title":"Cancer Lett"},{"key":"key20180107185539_b18-ijo-48-01-0409","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1186\/1472-6882-13-232","article-title":"Histone deacetylase (HDAC) inhibitory and antiproliferative activities of phenolic-rich extracts derived from the rhizome of Hydnophytum formicarum Jack: Sinapinic acid acts as HDAC inhibitor","volume":"13","author":"Senawong","year":"2013","journal-title":"BMC Complement Altern Med"},{"key":"key20180107185539_b19-ijo-48-01-0409","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0065-2571(84)90007-4","article-title":"Quantitative analysis of dose-effect relationships: The combined effects of multiple drugs or enzyme inhibitors","volume":"22","author":"Chou","year":"1984","journal-title":"Adv Enzyme Regul"},{"key":"key20180107185539_b20-ijo-48-01-0409","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1124\/pr.58.3.10","article-title":"Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies","volume":"58","author":"Chou","year":"2006","journal-title":"Pharmacol Rev"},{"key":"key20180107185539_b21-ijo-48-01-0409","doi-asserted-by":"crossref","first-page":"881","DOI":"10.7150\/ijms.5011","article-title":"Molecular mechanism of SAHA on regulation of autophagic cell death in tamoxifen-resistant MCF-7 breast cancer cells","volume":"9","author":"Lee","year":"2012","journal-title":"Int J Med Sci"},{"key":"key20180107185539_b22-ijo-48-01-0409","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1016\/j.athoracsur.2005.06.059","article-title":"Effectiveness of trichostatin A as a potential candidate for anticancer therapy in non-small-cell lung cancer","volume":"81","author":"Mukhopadhyay","year":"2006","journal-title":"Ann Thorac Surg"},{"key":"key20180107185539_b23-ijo-48-01-0409","doi-asserted-by":"crossref","first-page":"3113","DOI":"10.1158\/1078-0432.CCR-07-4836","article-title":"Evaluation of the in vitro and in vivo antitumor activity of histone deacetylase inhibitors for the therapy of retinoblastoma","volume":"14","author":"Dalgard","year":"2008","journal-title":"Clin Cancer Res"},{"key":"key20180107185539_b24-ijo-48-01-0409","first-page":"1181","article-title":"Chemosensitization of oral squamous cell carcinoma cells to cisplatin by histone deacetylase inhibitor, suberoylanilide hydroxamic acid","volume":"30","author":"Rikiishi","year":"2007","journal-title":"Int J Oncol"},{"key":"key20180107185539_b25-ijo-48-01-0409","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1016\/j.bcp.2007.03.009","article-title":"Enhancement of cisplatin induced apoptosis by suberoylanilide hydroxamic acid in human oral squamous cell carcinoma cell lines","volume":"73","author":"Shen","year":"2007","journal-title":"Biochem Pharmacol"},{"key":"key20180107185539_b26-ijo-48-01-0409","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1007\/s00280-009-0969-x","article-title":"Enhancement of cisplatin cytotoxicity by SAHA involves endoplasmic reticulum stress-mediated apoptosis in oral squamous cell carcinoma cells","volume":"64","author":"Suzuki","year":"2009","journal-title":"Cancer Chemother Pharmacol"},{"key":"key20180107185539_b27-ijo-48-01-0409","first-page":"7291","article-title":"Inhibition of histone deacetylase increases cytotoxicity to anticancer drugs targeting DNA","volume":"63","author":"Kim","year":"2003","journal-title":"Cancer Res"},{"key":"key20180107185539_b28-ijo-48-01-0409","first-page":"1705","article-title":"Synergistic effects of suberoylanilide hydroxamic acid combined with cisplatin causing cell cycle arrest independent apoptosis in platinum-resistant ovarian cancer cells","volume":"40","author":"Ong","year":"2012","journal-title":"Int J Oncol"},{"key":"key20180107185539_b29-ijo-48-01-0409","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1111\/j.1349-7006.2007.00669.x","article-title":"Histone deacetylase inhibitors enhance the chemosensitivity of tumor cells with cross-resistance to a wide range of DNA-damaging drugs","volume":"99","author":"Ozaki","year":"2008","journal-title":"Cancer Sci"},{"key":"key20180107185539_b30-ijo-48-01-0409","doi-asserted-by":"crossref","first-page":"4218","DOI":"10.2174\/092986712802884286","article-title":"The synergistic effects of DNA-targeted chemotherapeutics and histone deacetylase inhibitors as therapeutic strategies for cancer treatment","volume":"19","author":"Stiborov\u00e1","year":"2012","journal-title":"Curr Med Chem"},{"key":"key20180107185539_b31-ijo-48-01-0409","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1016\/j.juro.2010.10.034","article-title":"The histone deacetylase inhibitor trichostatin A synergistically resensitizes a cisplatin resistant human bladder cancer cell line","volume":"185","author":"Yoon","year":"2011","journal-title":"J Urol"},{"key":"key20180107185539_b32-ijo-48-01-0409","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.ejcb.2004.12.010","article-title":"Histone deacetylase inhibitors and cancer: From cell biology to the clinic","volume":"84","author":"Hess-Stumpp","year":"2005","journal-title":"Eur J Cell Biol"},{"key":"key20180107185539_b33-ijo-48-01-0409","first-page":"955","article-title":"Molecular basis of cellular response to cisplatin chemotherapy in non-small cell lung cancer (Review)","volume":"12","author":"Wang","year":"2004","journal-title":"Oncol Rep"},{"key":"key20180107185539_b34-ijo-48-01-0409","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1002\/ijc.10699","article-title":"Histone deacetylase inhibitor trichostatin A induces cell-cycle arrest\/apoptosis and hepatocyte differentiation in human hepatoma cells","volume":"103","author":"Yamashita","year":"2003","journal-title":"Int J Cancer"},{"key":"key20180107185539_b35-ijo-48-01-0409","first-page":"1585","article-title":"Suberoylanilide hydroxamic acid (SAHA) induces apoptosis or autophagy-associated cell death in chondrosarcoma cell lines","volume":"28","author":"Yamamoto","year":"2008","journal-title":"Anticancer Res"},{"key":"key20180107185539_b36-ijo-48-01-0409","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1002\/1097-0215(20001215)88:6<992::AID-IJC24>3.0.CO;2-9","article-title":"Effect of trichostatin A on cell growth and expression of cell cycle- and apoptosis-related molecules in human gastric and oral carcinoma cell lines","volume":"88","author":"Suzuki","year":"2000","journal-title":"Int J Cancer"},{"key":"key20180107185539_b37-ijo-48-01-0409","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1111\/cas.12271","article-title":"Alteration of cancer stem cell-like phenotype by histone deacetylase inhibitors in squamous cell carcinoma of the head and neck","volume":"104","author":"Chikamatsu","year":"2013","journal-title":"Cancer Sci"},{"key":"key20180107185539_b38-ijo-48-01-0409","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1038\/sj.onc.1204252","article-title":"Regulation of the G2\/M transition by p53","volume":"20","author":"Taylor","year":"2001","journal-title":"Oncogene"},{"key":"key20180107185539_b39-ijo-48-01-0409","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0304-3835(01)00720-0","article-title":"Induction of apoptosis by cisplatin and its effect on cell cycle-related proteins and cell cycle changes in hepatoma cells","volume":"175","author":"Qin","year":"2002","journal-title":"Cancer Lett"},{"key":"key20180107185539_b40-ijo-48-01-0409","doi-asserted-by":"crossref","first-page":"12579","DOI":"10.1074\/jbc.M213093200","article-title":"Role of caspases, Bid, and p53 in the apoptotic response triggered by histone deacetylase inhibitors trichostatin-A (TSA) and suberoylanilide hydroxamic acid (SAHA)","volume":"278","author":"Henderson","year":"2003","journal-title":"J Biol Chem"},{"key":"key20180107185539_b41-ijo-48-01-0409","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1158\/1535-7163.MCT-04-0107","article-title":"Histone deacetylase inhibitors induce G2-checkpoint arrest and apoptosis in cisplatinum-resistant ovarian cancer cells associated with overexpression of the Bcl-2-related protein Bad","volume":"4","author":"Strait","year":"2005","journal-title":"Mol Cancer Ther"},{"key":"key20180107185539_b42-ijo-48-01-0409","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1002\/ijc.22558","article-title":"Histone deacetylase inhibitor, suberoylanilide hydroxamic acid (Vorinostat, SAHA) profoundly inhibits the growth of human pancreatic cancer cells","volume":"121","author":"Kumagai","year":"2007","journal-title":"Int J Cancer"},{"key":"key20180107185539_b43-ijo-48-01-0409","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1111\/dote.12127","article-title":"Anticancer effects of suberoylanilide hydroxamic acid in esophageal squamous cancer cells in vitro and in vivo","volume":"27","author":"Tzao","year":"2014","journal-title":"Dis Esophagus"},{"key":"key20180107185539_b44-ijo-48-01-0409","first-page":"384","article-title":"The histone deacetylase inhibitor trichostatin A induces cell cycle arrest and apoptosis in colorectal cancer cells via p53-dependent and -independent pathways","volume":"28","author":"Meng","year":"2012","journal-title":"Oncol Rep"},{"key":"key20180107185539_b45-ijo-48-01-0409","first-page":"25","article-title":"Histone deacetylase-inhibitors sensitize human prostate cancer cell lines to growth suppression and apoptosis by retinoids","volume":"2","author":"Gu","year":"2006","journal-title":"J Cancer Mol"}],"container-title":["International Journal of Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/ijo.2015.3240\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T10:35:51Z","timestamp":1567334151000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/ijo.2015.3240"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11,9]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2015,11,9]]},"published-print":{"date-parts":[[2016,1]]}},"alternative-id":["10.3892\/ijo.2015.3240"],"URL":"https:\/\/doi.org\/10.3892\/ijo.2015.3240","relation":{},"ISSN":["1019-6439","1791-2423"],"issn-type":[{"value":"1019-6439","type":"print"},{"value":"1791-2423","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,11,9]]}}}